Improved survival and decreased cancer deaths in young adults with cancer after passage of the Affordable Care Act Dependent Coverage Expansion

Michael Roth,Clark R. Andersen,Amy Berkman,Stuart Siegel,Branko Cuglievan,J. Andrew Livingston,Michelle Hildebrandt,Jaime Estrada,Archie Bleyer
DOI: https://doi.org/10.1002/cncr.35538
IF: 6.9209
2024-10-07
Cancer
Abstract:Comparison of patients in the ACA DCE‐eligible age range (excluding ages and calendar years when patients with cancer would not have been eligible for DCE health insurance) versus younger and older patients in terms of changes in relative survival rates in the United States after an invasive cancer diagnosis from an average of 6 years before ACA enactment (2005–2010) to an average of the first 6 years after ACA enactment (2011–2016). ACA indicates the Patient Protection and Affordable Care Act; ACA DCE, Patient Protection and Affordable Care Act Dependent Coverage Expansion. Data source: the National Cancer Institute's Surveillance, Epidemiology and End Results 22 Regions, excluding Massachusetts and Illinois. Background The Patient Protection and Affordable Care Act (ACA) allowed Americans aged 19–25 years to remain on their parents' health insurance plans until age 26 years (the Dependent Care Expansion [DCE]). Have those with cancer diagnoses benefited? Methods The ACE DCE 7‐year age range of 19–25 years was compared for changes in cancer survival and mortality before and after enactment of the ACA with groups that were younger and older (in 7‐year age spans: ages 12–18 and 26–32 years, respectively). Cancer death data for the entire United States were obtained from the Centers for Disease Control and Prevention, and relative survival data of patients who were diagnosed with cancer were obtained from the National Cancer Institute Surveillance, Epidemiology, and End Results regions representing 42%–44% of the country. Results Joinpoint analysis identified the DCE‐eligible cohort as the only age group of the three groups evaluated that have had improvements in both cancer survival and death rate trends after ACA implementation and that 2010, the year the ACA was passed, was the inflection year for both survival and deaths. By 6 years, the relative survival after cancer diagnosis was 2.6 and 3.9 times greater in the DCE‐eligible age group than in the younger and older control groups, respectively (both p
oncology
What problem does this paper attempt to address?